(Cleaning up.) |
|||
| Line 106: | Line 106: | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
[[Category:Psychedelic]] | [[Category:Psychedelic]] | ||
| + | [[Category:Research Chemical]] | ||
2C-D is a short acting psychedelic drug of the 2C-X family. The effects of 2C-D are usually compared to 2C-B (although not as visual as 2C-B) or other psychedelic stimulants and sometimes to MDMA (ecstasy). Its effects are generally considered milder than 2C-B, LSD, or MDMA. 2C-D is also known for the strong body component of its effects which are alternately described as pleasurable energy or a 'sense of being in the body', and by others as an unpleasant 'buzzing' or body-load, which is mostly occurring during onset. Shulgin himself referred to this substance as a “pharmacological tofu,” meaning that when mixed with other substances, it can extend or potentiate their effects without coloring the experience too much, in a manner similar to how tofu absorbs the flavors of sauces or spices it is cooked with. Some people have claimed 2C-D is relatively uninteresting on its own, but many other users have strongly disagreed with this assessment and believe instead 2C-D to be a true psychedelic in its own right.
It was first synthesized in 1970 by a team from the Texas Research Institute of Mental Sciences, and its activity was subsequently investigated in humans by Alexander Shulgin.
2C-D is one of the safer psychedelics, with several reported cases of users far exceeding commonly used dosing limits without lasting adverse physical effects. It is also observed to have a low addiction potential. It is a stimulating psychedelic, and therefore it's important to remain hydrated. Refer to Psychedelic Harm Reduction for more information.
